Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Trading Up 1.6 %

Shares of RVP stock opened at $0.73 on Wednesday. Retractable Technologies has a 12-month low of $0.56 and a 12-month high of $1.23. The company has a market capitalization of $21.71 million, a P/E ratio of -1.34 and a beta of 2.08. The firm has a 50-day moving average price of $0.78 and a 200 day moving average price of $0.75. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. Wealthfront Advisers LLC acquired a new stake in Retractable Technologies, Inc. (NYSE:RVP) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned approximately 8.46% of Retractable Technologies at the end of the most recent quarter. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.